Article

Necrolytic Acral Erythema: An Expanding Spectrum

Author and Disclosure Information

Hepatitis C virus (HCV) infection is the most common chronic blood-borne viral infection in the United States. Well-described cutaneous manifestations of HCV infection include polyarteritis nodosa, porphyria cutanea tarda, type II cryoglobulinemia–associated vasculitis, pruritus, erythema nodosum, urticaria and urticarial vasculitis, lichen planus, and erythema multiforme. First described in 1996, necrolytic acral erythema (NAE) is now recognized as a cutaneous acral eruption uniquely associated with HCV infection. Most patients present with chronic, acral, erythematous, and psoriasiform lesions. Acute presentations of NAE are rare and patients may present with atypical clinical features; in these cases, suspicion for HCV infection may be delayed for weeks to months until more classic chronic lesions develop. In many cases, NAE presents before the patient has been diagnosed with HCV infection, which allows dermatologists the unique opportunity to suspect and diagnose HCV infection based on skin findings alone.


 

Recommended Reading

CPT Codes for H1N1 Vaccine Are Released
MDedge Dermatology
Parents Not Keen on H1N1 Vaccine for Children
MDedge Dermatology
CDC Officials Continue to Urge Priority Groups to Receive Pandemic Flu Vaccine
MDedge Dermatology
Investigational Antibiotic for MRSA Found Effective, Safe
MDedge Dermatology
New Cream May Prevent Cold Sore Recurrence
MDedge Dermatology
FDA Approves Gardasil for Boys and Cervarix for Girls
MDedge Dermatology
DNA Technology May Revolutionize Flu Vaccine
MDedge Dermatology
2010 Travel Health Book Is Now Online
MDedge Dermatology
Ecthyma Gangrenosum Caused by Escherichia coli Bacteremia: A Case Report and Review of the Literature
MDedge Dermatology
Cutaneous and Systemic Infection With Scedosporium apiospermum
MDedge Dermatology